Real-time enrollment status for this h5n1 influenza clinical trial
Current Status
Completed
Checked: March 2, 2026 at 8:47 AM UTC
| NCT Number | NCT06382311 |
| Recruiting Status | Completed |
| Condition | H5N1 Influenza |
| Phase | Clinical Trial |
| Target Enrollment | 996 participants |
| Active Locations | 21 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | February 5, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT06382311 is currently completed participants. This clinical trial study for h5n1 influenza is not currently accepting new participants at 21 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06382311 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06382311 was last updated 3 weeks ago (February 5, 2026). HelloStudys verifies this status automatically.